These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23244375)

  • 1. The safe and appropriate use of systemic glucocorticoids in treating dermatologic disease.
    Werth VP
    J Am Acad Dermatol; 2013 Jan; 68(1):177-8. PubMed ID: 23244375
    [No Abstract]   [Full Text] [Related]  

  • 2. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the dermatologic use of systemic glucocorticosteroids.
    Jackson S; Gilchrist H; Nesbitt LT
    Dermatol Ther; 2007; 20(4):187-205. PubMed ID: 17970885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Down to skin and bone'.
    Cameron F
    Australas J Dermatol; 2000 Aug; 41(3):146-8. PubMed ID: 10954984
    [No Abstract]   [Full Text] [Related]  

  • 5. Iatrogenic osteoporosis in dermatology.
    Foo CW; Yukumoto E; DeJournett R; Johnson DW
    Int J Dermatol; 2009 Oct; 48(10):1035-42; quiz 1042-3. PubMed ID: 19775397
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT; Yosipovitch G
    Arch Dermatol; 2006 Jan; 142(1):82-90. PubMed ID: 16415391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular triamcinolone: a safe, effective and underutilized dermatologic therapy.
    Robins DN
    J Drugs Dermatol; 2009 Jun; 8(6):580-5. PubMed ID: 19537385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of osteoporosis and the use of bone protective therapies in dermatology clinic patients on long-term glucocorticoids.
    Abell S; Zeimer H; Chong A; MacIsaac RJ
    Australas J Dermatol; 2015 May; 56(2):147-8. PubMed ID: 25900638
    [No Abstract]   [Full Text] [Related]  

  • 9. Dermatologic use of glucocorticoids. Systemic and topical.
    Scott DW
    Vet Clin North Am Small Anim Pract; 1982 Feb; 12(1):19-32. PubMed ID: 7048711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic glucocorticosteroid therapy in dermatology.
    Hilton DC; Williams LC; Nesbitt LT
    Dermatol Nurs; 2000 Aug; 12(4):258-63; quiz 264-5. PubMed ID: 11912664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of systemic glucocorticoid side effects.
    Moghadam-Kia S; Werth VP
    Int J Dermatol; 2010 Mar; 49(3):239-48. PubMed ID: 20465658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corticosteroid therapy in dermatology].
    Tronnier H
    Z Allgemeinmed; 1969 Jul; 45(21):985-94. PubMed ID: 5354164
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with a new therapeutic principle in dermatologic practice].
    Schmidt R
    Landarzt; 1968 Dec; 44(34):1686-8. PubMed ID: 5730433
    [No Abstract]   [Full Text] [Related]  

  • 14. [External use of corticosteroids and testing of their efficacy].
    Tronnier H
    Landarzt; 1968 Feb; 44(5):227-30. PubMed ID: 5716603
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cortisone cataract in skin diseases].
    Happle R; Damaske E
    Hautarzt; 1974 Sep; 25(9):437-9. PubMed ID: 4459330
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic glucocorticosteroid therapy of skin disease in children.
    Fritz KA; Weston WL
    Pediatr Dermatol; 1984 Jan; 1(3):236-45. PubMed ID: 6387668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local therapy with corticoids].
    Schalla W
    Z Hautkr; 1985 Apr; 60(7):609-18. PubMed ID: 4002771
    [No Abstract]   [Full Text] [Related]  

  • 18. [Management of osteoporosis in patients with inhaled glucocorticoids].
    Wada S; Kamiya S; Fukawa T
    Clin Calcium; 2006 Nov; 16(11):1871-77. PubMed ID: 17079855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy with systemic glucocorticoids].
    Niedner R
    Hautarzt; 2001 Nov; 52(11):1062-71; quiz 1072-4. PubMed ID: 11757464
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimizing complications from systemic glucocorticosteroid use.
    Nesbitt LT
    Dermatol Clin; 1995 Oct; 13(4):925-39. PubMed ID: 8785896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.